Ludmila Boudova
Overview
Explore the profile of Ludmila Boudova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saft L, Kvasnicka H, Boudova L, Gianelli U, Lazzi S, Rozman M
Histopathology
. 2023 Aug;
83(6):829-849.
PMID: 37551450
Myeloid/lymphoid neoplasms with eosinophilia (M/LN-eo) and tyrosine kinase (TK) gene fusions are a rare group of haematopoietic neoplasms with a broad range of clinical and morphological presentations. Paediatric cases have...
2.
Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin M, Boudova L, et al.
Mod Pathol
. 2022 Nov;
35(12):2023-2024.
PMID: 36333474
No abstract available.
3.
Hebeda K, Boudova L, Beham-Schmid C, Orazi A, Kvasnicka H, Gianelli U, et al.
Ann Hematol
. 2020 Oct;
100(1):117-133.
PMID: 33128619
Disease progression in myelodysplastic syndromes (MDS) and myelodysplastic-myeloproliferative neoplasms (MDS/MPN) is a major source of mortality. The European Bone Marrow Working Group organized a dedicated workshop to address MDS and...
4.
Kastnerova L, Belousova I, Hadravsky L, Kerl H, Cerroni L, Kerl K, et al.
Am J Dermatopathol
. 2019 Jun;
42(1):24-28.
PMID: 31169526
Specific cutaneous involvement in Hodgkin lymphoma is rare. In cutaneous lesions, the diagnosis is usually based on the recognition of diagnostic Reed-Sternberg cells and its variants. In nodal Hodgkin lymphoma,...
5.
Klener P, Salek D, Pytlik R, Mocikova H, Forsterova K, Blahovcova P, et al.
Am J Hematol
. 2018 Nov;
94(2):E50-E53.
PMID: 30474171
No abstract available.
6.
Hebeda K, Tzankov A, Boudova L, Saft L, Hasserjian R, de Boer M, et al.
Pathobiology
. 2018 Jul;
86(1):62-75.
PMID: 29982244
The 13th workshop of the European Bone Marrow Working Group in Utrecht, The Netherlands, was devoted to studying myelodysplastic syndromes (MDS) and their boundaries. The panel received 44 cases submitted...
7.
Vesela P, Tonar Z, Boudova L
Cesk Patol
. 2015 May;
51(2):94-8.
PMID: 25970722
In recent years antiangiogenic therapy has become a part of treatment protocols of solid tumors as well as of lymphomas. This is why tumor vascularization has been explored, the most...
8.
Vesela P, Tonar Z, Salek D, Vokurka S, Trneny M, Kodet R, et al.
Virchows Arch
. 2014 Jul;
465(5):587-97.
PMID: 25048573
The clinical course and therapy of mantle cell lymphoma (MCL) are heterogeneous and often unsatisfactory. Prognostic factors are needed to stratify the patients. Microvessel density (MVD) has prognostic significance in...
9.
Adam P, Czapiewski P, Colak S, Kosmidis P, Tousseyn T, Sagaert X, et al.
Br J Haematol
. 2013 Dec;
164(6):804-10.
PMID: 24372375
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) comprises 7-8% of B-cell lymphomas and commonly originates from a background of long-standing chronic inflammation. An association with distinct bacteria...
10.
Salek D, Vesela P, Boudova L, Janikova A, Klener P, Vokurka S, et al.
Leuk Lymphoma
. 2013 Jun;
55(4):802-10.
PMID: 23772666
Although a prognostic model (MIPI, Mantle Cell Lymphoma International Prognostic Index) for patients with mantle cell lymphoma (MCL) has been established, its clinical significance for daily practice in the rituximab...